EarningsQ3 2025 Earnings Report

ACADIA Pharmaceuticals (ACAD) Q3 2025 Earnings Report

0 Followers

MX:ACAD Q3 2025 EPS Results

Actual EPS$7.63

Consensus EPS$3.14

Beat/MissBeat by +$4.49

One Year Ago EPS$3.64

Actual Revenue$5.07B

Expected Revenue$5.03B

Beat/MissBeat by +$38.03M

YoY Revenue Growth+11.27%

QuarterQ3 2025

Date11/05/2025

TimeAfter Close

Conference CallWednesday, November 5, 2025

MX:ACAD Upcoming Earnings

ACADIA Pharmaceuticals's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

MX:ACAD Q3 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	3.60 / -	7.635	―
Aug 04, 2026	2026 (Q2)	1.24 / 3.27	2.909	12.50% (+0.36)
May 06, 2026	2026 (Q1)	0.93 / 0.36	2	-81.82% (-1.64)
Feb 25, 2026	2025 (Q4)	2.49 / 29.09	15.633	86.05% (+13.45)
Nov 05, 2025	2025 (Q3)	3.14 / 7.63	3.636	110.00% (+4.00)
Aug 06, 2025	2025 (Q2)	2.51 / 2.91	3.636	-20.00% (-0.73)
May 07, 2025	2025 (Q1)	1.58 / 2.00	1.818	10.00% (+0.18)
Feb 26, 2025	2024 (Q4)	3.93 / 15.63	5.09	207.14% (+10.54)
Nov 06, 2024	2024 (Q3)	2.51 / 3.64	-7.271	150.00% (+10.91)
Aug 06, 2024	2024 (Q2)	3.24 / 3.64	0.182	1900.00% (+3.45)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed